Illumina’s stunning victory against EU regulators changes the game for mergers
In a landmark decision that could redefine the boundaries of European merger control, the Court of Justice of the European Union (CJEU) ruled in favor ... Read More
Illumina secures FDA approval for comprehensive cancer test and two companion diagnostics
Illumina, Inc. (NASDAQ: ILMN), a global leader in the field of DNA sequencing and array-based technologies, has secured crucial approval from the Food and Drug ... Read More
European Commission approves Illumina’s divestment plan for GRAIL
The European Commission, exercising its authority under the EU Merger Regulation (EUMR), has granted approval to Illumina's proposed divestment of GRAIL. This decision, crucial for ... Read More
Illumina to take full ownership of cancer screening company GRAIL in $8bn deal
Illumina acquisition of GRAIL : US sequencing company Illumina has agreed to fully acquire California-based cancer screening company GRAIL in a cash and stock deal ... Read More